NCT00080587
- Conditions
- Arterial Occlusive Diseases, Arteriosclerosis, Cardiovascular Diseases, +10 more
- Locations
-
- National Heart, Lung and Blood Institute (NHLBI) Bethesda, Maryland, United States
Clinical trial condition
Hyperlipidemias
Explore clinical trials studying Hyperlipidemias. Study availability and eligibility vary by location and protocol.
691 public trials
57 recruiting studies
Hyperlipidemias trial results
NCT00001142
- Conditions
- Blood-Borne Infections, Communicable Diseases, Disease Attributes, +29 more
- Locations
-
- National Institute of Child Health and Human Development (NICHD) Bethesda, Maryland, United States
NCT00222833
- Conditions
- Body Weight, Cardiovascular Diseases, Dyslipidemias, +15 more
- Locations
-
- Western Psychiatric Institute and Clinic of UPMC Pittsburgh, Pennsylvania, United States
NCT00287404
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Dyslipidemias, +7 more
- Locations
-
- University of North Carolina Diabetes Care Center Durham, North Carolina, United States
NCT00134173
- Conditions
- Arterial Occlusive Diseases, Arteriosclerosis, Cardiovascular Diseases, +12 more
- Locations
-
- Pfizer Investigational Site Birmingham, Alabama, United States
- Pfizer Investigational Site Mobile, Alabama, United States
- Pfizer Investigational Site Little Rock, Arkansas, United States
- Pfizer Investigational Site Fresno, California, United States
NCT00566267
- Conditions
- Dyslipidemias, Hyperlipidemia, Hyperlipidemias, +3 more
- Locations
-
Not specified
NCT00267254
- Conditions
- Dyslipidemia, Dyslipidemias, Hypercholesterolemia, +5 more
- Locations
-
- Pfizer Investigational Site Birmingham, Alabama, United States
- Pfizer Investigational Site Mobile, Alabama, United States
- Pfizer Investigational Site Mesa, Arizona, United States
- Pfizer Investigational Site Phoenix, Arizona, United States
NCT00137462
- Conditions
- Dyslipidemias, Hyperlipidemia, Hyperlipidemias, +3 more
- Locations
-
- Pfizer Investigational Site Huntsville, Alabama, United States
- Pfizer Investigational Site Union Grove, Alabama, United States
- Pfizer Investigational Site Fresno, California, United States
- Pfizer Investigational Site Los Angeles, California, United States
NCT00405769
- Conditions
- Arterial Occlusive Diseases, Arteriosclerosis, Cardiovascular Diseases, +11 more
- Locations
-
- Chestnut Hill Hospital Philadelphia, Pennsylvania, United States
Completed
Assess HDL-C Increase And Non-HDL Lowering Effect Of Torcetrapib/Atorvastatin Vs. Fenofibrate
NCT00139061
- Conditions
- Dyslipidemias, Hyperlipidemia, Hyperlipidemias, +3 more
- Locations
-
- Pfizer Investigational Site Angers, France
- Pfizer Investigational Site Angers, France
- Pfizer Investigational Site Bordeaux Cauderan, France
- Pfizer Investigational Site Briollay, France